📰 ET Markets 🟢 BULLISH 🕒 04 Nov 2026, 09:19 AM IST

NSE shares in focus after Q2 net profit rises 23% YoY. Why Jefferies, other brokerages remain bullish?

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: NSE shares in focus after Q2 net profit rises 23% YoY. Why Jefferies, other brokerages remain bullish?

📊

Market & Financial Impact: NSE reported a 23% year-on-year rise in Q2 FY27 consolidated net profit to Rs 2,578 crore, driven by higher trading volumes and transaction revenue. The exchange also approved divesting up to 40% stake in its coal exchange subsidiary. Jefferies and Emkay maintained Buy ratings, projecting further upside in NSE shares.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Along with the Q2 results, NSE announced that its board has approved the divestment of up to 40% stake in National Coal Exchange of India Limited.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Some elections matter more than you know: No crop changed in the fields, yet sugar, coffee and soya got cheaper in a day

You can buy a walkie-talkie online. But can you legally use it?

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

NSE shares in focus after Q2 net profit rises 23% YoY. Why Jefferies, other brokerages remain bullish?

🔥 More Live Market Stories

Brent crude slips below $103, WTI near $95 as investors track US midterm election results, Middle East peace talks

India has democratised market access without demystifying market advantage

Buzzing Stocks: GNG Electronics share price jumps 8% on strong Q2 results; JNK India gains 2% on order win.

Price Action: Global Health up 6%, Vijaya Diagnostic down 3% post Q2 earnings

[HIRECT] Analysts/Institutional Investor Meet/Con. Call Updates - Hirect Limited

[AZAD] Analysts/Institutional Investor Meet/Con. Call Updates - Azad Engineering Limited